Surrozen, SZN-8141, Diabetic Macular Edema, DME, Wnt Signaling, FZD4, VEGF, Retinal Disease, Ophthalmology, Gene Therapy, Wet AMD, Age-Related Macular Degeneration

SOUTH SAN FRANCISCO, Calif. — October 2, 2026 Surrozen, Inc. announced that the U.S. Food and Drug Administration (FDA)...